维普期刊资源整合服务平台（V6.5）

178篇 您的检索式：作者名="Jerums"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Effects of glycaemic management on diabetic kidney disease显示文摘Hyperglycaemia contributes to the onset and progression of diabetic kidney disease(DKD). Observational studies have not consistently demonstrated a glucose threshold, in terms of HbA1c levels, for the onset of DKD. Tight glucose control has clearly been shown to reduce the incidence of micro-or macroalbuminuria. However, evidence is now also emerging to suggest that intensive glucose control can slow glomerular filtration rate loss and possibly progression to end stage kidney disease. Achieving tight glucose control needs to be balanced against the increasing appreciation that glucose targets for the prevention of diabetes related complications need be individualised for each patient. Recently, empagliflozin which is an oral glucose lowering agent of the sodium glucose cotransporter-2 inhibitor class has been shown to have renal protective effects. However, the magnitude of empagliflozin's reno-protective properties are over and above that expected from its glucose lowering effects and most likely largely result from mechanisms involving alterations in intra-renal haemodynamics. Liraglutide and semaglutide, both injectable glucose lowering agents which are analogues of human glucagon like peptide-1 have also been shown to reduce progression to macroalbuminuria through mechanisms that remain to be fully elucidated. Here we review the evidence from observational and interventional studies that link good glucose control with improved renal outcomes. We also briefly review the potential reno-protective effects ofnewer glucose lowering agents.	Richard J MacIsaac George Jerums Elif I Ekinci	2017	World Journal of Diabetes2017，8，5：	6
2	A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia显示文摘	Anthony Dart George Jerums Geoffrey Nicholson Michael d’Emden Ian Hamilton-Craig George Tallis James Best Malcolm West David Sullivan Peter Braes Donald Black	1997	The American Journal of Cardiology1997，，：	2
3	Integrating albu-minuria and GFR in the assessment of diabetic nephropathy 显示文摘	Jerums G Panagiotopoulos S Premaratne E	2009	Na-ture Reviews Nephrology2009，5，7：	1
4	Lowering of Proteinuria in Response to Antihypertensive Therapy Predicts Improved Renal Function in Late but Not in Early Diabetic Nephropathy: A Pooled Analysis显示文摘	Jerums George Panagiotopoulos Sianna Premaratne Erosha Power David A Macisaac Richard J	2008	American Journal of Nephrology2008，，4：	1
5	Estimating glomerular filtration rate in diabetes using serum cystatin C 显示文摘	Macisaac R J Premaratne E Jerums G	2011	Clin Biochem Rev2011，32，2：	1
6	Long-term comparison between perindopril and nifedipine in normotensive patients with type Ⅰ diabetes and microalbuminuria 显示文摘	Jerums G Allen TJ Campbell DJ	2006	Am J Kidney Dis2006，37，5：	1
7	Integrating albuminuria and GFR in the assessment of diabetic nephropathy显示文摘	Jerums G Panagiotopoulos S Premaratne E		0，，：	1
8	Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function显示文摘	Ekinci EI Jerums G Skene A		0，，：	1
9	long-term Comparison between perimelopril and nifedipine in normotenive patients with type I diabetes and mieroalbuminttria显示文摘	Jerums G Campbell DJ	2001	Am J Kidney Dis2001，37，5：	1
10	Integrating albuminuria and GFR in the assessment of diabetic nephropathy显示文摘	JERUMS G PANAGIOTOPOULOS S PREMARATNE E	2009	Nat Rev Nephrol2009，5，7：	1
11	Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography 显示文摘	Comper WD Jerums G Osicka TM	2004	Clin Biochem2004，37，2：	1
12	Renal structure in normoalbumi-nuric and albuminuric patients with type 2 diabetes and impaired renal function显示文摘	Ekinci EI Jerums G Skene A	2013	Diabetes Care2013，36，11：	1
13	Urinary proteomics for early diagosis in diabetic nephropathy显示文摘	Zurbig P Jerums G Hovind P	2012	Diabetes2012，61，12：	1
14	New and old markers of progression of diabetic nephropathy显示文摘	Jerums G Premaratne E Panagiotopoulos S Clarke S Power D A Maclsaac R J	2008	Diabetes Res Clin Pract2008，82，1：	1
15	Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography 显示文摘	Comper WD Jerums G Osicka TM	2004	Clin Bioehem2004，37，2：	1
16	Estimating glo merular filtration rate in diabetes using serum cystatin C 显示文摘	Maeisaae RJ Premaratne E Jerums G	2011	Clin Biochem Rev2011，32，2：	1
17	Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy显示文摘	Kelly DJ Gilbert RE Cox AJ Soulis T Jerums G Cooper ME	2001	J Am Soc Nephrol2001，12，：	1
18	Estimating glomerular fil- tration rate in diabetes using serum cystatin C显示文摘	Maeisaae RJ Premaratne E Jerums G	2011	Clin Biochem Rev2011，32，2：	1
19	Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes显示文摘	R. E. Gilbert D. J. Kelly A. J. Cox J. L. Wilkinson-Berka J. R. Rumble T. Osicka S. Panagiotopoulos V. Lee E. C. Hendrich G. Jerums M. E. Cooper	2000	Diabetologia2000，，11：	1
20	Differcnccs in urinary alburain detected by four immunoassays and high performance liquid chromatography显示文摘	Comper WD Jerums G Osicka TM	2004	Clin Biochem2004，37，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示